« FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid | Main | FDA Announces Revisions to Labels for Cialis, Levitra and Viagra »

Schering-Plough's Shares Fall After Earnings Miss (Update1) (Bloomberg.com) Oct. 22


Schering-Plough's Shares Fall After Earnings Miss (Update1) (Bloomberg.com)
Oct. 22 (Bloomberg) -- Schering-Plough Corp. fell the most in more than six years in New York trading on slowed growth for its cholesterol drugs and higher research costs.
 

©2006 FDA-News.com. All rights reserved.